| Peptide | CAS-no | VPAC1R | VPAC2R | PAC1R | References |
| VIP | 37221-79-7 | agonist | agonist |
| [102] |
| PG-96-237 |
|
|
|
| [101] |
| PG 96-238 | 309728-48-1 | antagonist | antagonist | partial agonist | [95] |
| PG 97-269 | 202463-00-1 | antagonist |
|
| [103] [104] |
| PG 97-277 | 139308543 | partial agonist |
|
| [101] |
| PG 97-278 | 1392912-99-0 | partial antagonist | agonist |
| [101] |
| PG 99-465 | 309913-26-6 | fullagonist | antagonist partial agonist | fullagonist | [47] [101] [104] [105] |
| Bay 55-9837 | 46390-25-8 |
| agonist |
| [10] [16] [55] [103] [106] |
| Ro 25-1392 | 150828-75-4 |
| agonist |
| [107] |
| Ro 25-1553 | 159704-87-6 |
| agonist |
| [71] [102] |
| [Ala11,22,28]VIP |
| antagonist |
|
| [59] |
| PACAP (6-38) | 143748-18.9 | antagonist | antagonist | antagonist | [47] [63] [104] [109] |
| M65 |
|
|
| antagonist | [109] |
| Maxadilan | 515114-03-1 |
|
| agonist | [63] [110] [111] |
| Maxadilan d.4 |
|
| antagonist |
| [63] [110] [111] |
| PACAP27 | 129069-75-6 |
|
| agonist | [109] |
| PACAP38 | 137061-48-4 |
|
| agonist | [109] |